CRL vs FBIN · rev $2.00B vs P/E 16, rev $2.17B
Charles River Laboratories (CRL) versus Fortune Brands Innovations Inc. (FBIN) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Fortune Brands Innovations Inc. (FBIN) is a building products & equipment company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported FBIN revenue for 2026-06-27 was $2.17B. Net income was $1.7M. FBIN currently screens at market cap $6.39B and trailing P/E 15.6.
CRL currently screens at market cap $7.78B. FBIN currently screens at market cap $6.39B and trailing P/E 15.6.
Not investment advice. Open the CRL and FBIN stock pages for the full models.
Not investment advice.